To explore whether systemically delivered VINAS gapmeRs modulate atherosclerosis, LDLR–/– mice received i.v. injections of vehicle control or VINAS gapmeR (10 mg/kg/2 times weekly) over 12 weeks on an HCD (Figure 5A). Here, LDLR is linked to atherosclerosis.